Dennis M. Brown - 05 Jan 2023 Form 4 Insider Report for Kintara Therapeutics, Inc. (HURA)

Role: Chief Scientific Officer
Signature: /s/ Anthony Scott Praill, attorney-in-fact for Dennis M. Brown
Issuer symbol: HURA
Transactions as of: 05 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 06 Jan 2023, 18:26:18 UTC
Previous filing: 03 Aug 2022
Next filing: 01 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KTRA	Common Stock, par value $0.001 per share	Will/Inheritance	$0	+363	+7.3%	$0.000000	5,302	05 Jan 2023	Direct	F1
holding	KTRA	Common Stock, par value $0.001 per share						1,075	05 Jan 2023	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 4,801 restricted stock units that are unvested.
F2	Shares held by Valent Technologies LLC, of which the Reporting Person is the sole member and owner and holds sole voting and dispositive power over its shares.

Remarks:

The shares reported on this Form 4 have been adjusted to reflect the Issuer's 1-for-50 reverse stock split of its common stock, effective November 11, 2022.